聯合骨科器材股份有限公司 Approved
最後更新時間 2025/07/13 , 02:43 AM
最後更新時間 2025/07/13 , 02:43 AM
負責人
Lin,Yan-Sheng
統一編號
22099982
成立日期
1993/03/05
資本額
NT$1,500,000,000
實收資本額
NT$964,367,040
股票代號
4129
電話
#1101
地址
1F, No. 57, Yuancyu 2nd Rd., Hsinchu City, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Lin,Yan-Sheng Chairman 2.72%
Lin,De-Jian Director 1.53%
Hao,Hai-Yan Director 0.79%
Wu,Chu-Hua Director 1.73%
Hong,Zhong-Kai Director 3.23% YI SHENG Co., Ltd.
Liu,Jian-Lin Independent Director 0.20%
Li,Kun-Zhang Independent Director 0.00%
Wu,Meng-Da Independent Director 0.00%
Chen,Li-Ru Independent Director 0.00%
營業項目
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • 公司歷程
  • Change Capital to 1,500,000,000
    2019/06/28
  • Change Capital to 1,000,000,000
    2015/11/19
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 1,297,172 4,653,130 3,929,887
    Operating cost 251,089 1,030,809 893,517
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 1,046,083 3,622,321 3,036,370
    Unrealized profit (loss) on sales of goods -3,019 - 0
    Realized profit (loss) on sales of goods - 204 15,005
    Operating gross profit (loss), net 1,049,102 3,622,525 3,051,375
    Operating expenses 856,165 3,013,537 2,508,106
    Other gain (loss), net - - 0
    Operating profit (loss) 192,937 608,988 543,269
    Non-operating income and expenses 70,228 -33,884 -34,043
    Net profit (loss) before tax 263,165 575,104 509,226
    Income tax expense (benefits) 70,017 114,723 120,917
    Net profit (loss) of ongoing business for the current period 193,148 460,381 388,309
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 193,148 460,381 388,309
    Other comprehensive profit (loss), net 40,795 43,919 -3,875
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 233,943 504,300 384,434
    Net profit (loss) attributable to owners of parent company 190,845 456,428 384,201
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests 2,303 3,953 4,108
    Comprehensive profit (loss) attributable to owners of parent company 230,594 499,897 379,951
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests 3,349 4,403 4,483
    Basic earnings per share (yuan) 1 4 4
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 186,647 717,289 433,729
    Net cash inflows (outflows) from investing activities -125,537 -563,600 -469,713
    Net cash inflow (outflow) from financing activities -163,468 -14,339 109,408
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 9,133 22,312 -22,461
    Increase (decrease) in cash and cash equivalents in the current period -93,225 161,662 50,963
    Beginning balance of cash and cash equivalents 610,682 449,020 398,057
    Ending balance of cash and cash equivalents 517,457 610,682 449,020
    項目 2025 2024 2023
    Current asset 3,913,544 3,822,404 3,383,788
    Non-current asset 3,286,583 3,217,083 3,033,082
    Total asset 7,200,127 7,039,487 6,416,870
    Current liability 2,429,274 2,470,798 1,890,865
    Non-current liability 586,949 618,728 931,932
    Total liability 3,016,223 3,089,526 2,822,797
    share capital 964,367 964,367 925,287
    Equity - secruity token - - -
    capital reserve 2,223,879 2,223,879 2,023,236
    retained earning 919,485 728,640 651,195
    Other equity -24,598 -64,347 -102,045
    Treasury stock - - 0
    Total equity attributable to owners of parent company 4,083,133 3,852,539 3,497,673
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 100,771 97,422 96,400
    Total Equity 4,183,904 3,949,961 3,594,073
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 42 39 39
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 聯合骨科器材股份有限公司標章
  • United
  • 聯合骨科標章
  • United orthopedic corporation
  • U2Knee Tunes for your knee Surgery.
  • U2
  • Unify
  • 優華
  • UOC
  • 聯合 2000 U2
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Confirmation of the existence of employment relationship, etc
    2018, 2019
  • Others
    2006
  • Pay the ticket
    2002
  • Pay for the goods
    2001, 2003
  • Invalidating Judgment
    2010
  • Petition filed for public summons
    2010
  • Act of Gender Equality in Employment
    2021
  • Profit-seeking Enterprise Income Tax
    2008, 2010
  • Confirmation of the existence of employment relationship, etc
    2021, 2022, 2023
  • Request for confirmation of the existence of the employment relationship, etc.
    2022, 2023
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。